The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Surgical resection is the mainstay of treatment for locally advanced esophageal cancer. Neoadjuvant therapy is recommended to improve survival, based on the results of sev-eral randomized trials and meta-analyses. However, controversy remains regarding how to combine surgery, radiotherapy, and chemo...
Main Authors: | Dongryul Oh, Jong Hoon Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for Thoracic and Cardiovascular Surgery
2020-08-01
|
Series: | Korean Journal of Thoracic and Cardiovascular Surgery |
Subjects: |
Similar Items
-
Progress in Multimodal Treatment for Advanced Esophageal Squamous Cell Carcinoma: Results of Multi-Institutional Trials Conducted in Japan
by: Kazuo Koyanagi, et al.
Published: (2021-12-01) -
Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?
by: Xu Yaping, et al.
Published: (2012-08-01) -
Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer
by: Shuhei Mayanagi, et al.
Published: (2019-05-01) -
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)
by: Hai-Bo Sun, et al.
Published: (2020-04-01) -
Predictive value of neutrophil-lymphocyte ratio in preoperative neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
by: XIONG Kai, et al.
Published: (2021-01-01)